论文部分内容阅读
Objective The restoration of HBV-specific T-cell response during antiviral therapy is associated with CD4+T-cell activity.Treg cells and Th17 cells are the new subtypes of CD4+T cell.However,it remains unknown how the Treg and Th 17 cells and their associated cytokines affect nucleos(t) analogues (NA) antiviral efficacy.